Overview A global biopharmaceutical company on a mission to Solve On Incyte follows science to find solutions for patients with unmet medical needs. Through the discovery development and commercialization of proprietary therapeutics Incyte has established a portfolio of first-in-class medicines for patients and a strong pipeline of products in Hematology Oncology and Inflammation and Autoimmunity Headquartered in Wilmington Delaware Incyte has operations in North America Europe and Asia. Sr. Director New Product Planning NPP Lead serves as the strategic bridge between R&D Global and US Commercial shaping oncology assets 2-5 years prior to launch. This role drives asset strategy market development and organizational readiness to maximize long-term value and ensure successful commercialization in new disease areas. The position operates in a highly matrixed environment and plays a central role in portfolio decision-making clinical development influence and pre-launch strategy formation. Core Responsibilities Product Planning Co-develop Target Product Profiles TPPs provide US commercial input to trial designevidence generation regulatorylabeling strategy and differentiation vs. standard of care translate scientific and clinical data into commercial implications risks and opportunities support assets from preclinical through Phase IIIII decision points. Market Shaping Build deep understanding of disease biologyparadigm patient segmentationunmet need and competitive pipeline lead market-shaping strategies disease awareness diagnostic pathway evolution KOL engagement scientific leadership positioning early value propositionpositioning generate insights through primary research competitive intelligence and analog analysis anticipate future market dynamics and access environment pricing reimbursement guidelines. Shape portfolio & investment decisions Lead US commercial assessments market sizingepidemiologypatient flow forecastingvaluation scenario planningrisk support governance forums portfolio prioritization stage-gate decisions BDlicensing evaluations recommend where to invest vs. deprioritize. Organizational Readiness Drive cross-functional alignment R&D Medical Market Access Regulatory Commercial build early brand strategy and launch blueprint positioning value story evidence plan go-to-market hypotheses define required future capabilities field model diagnostics patient identification payer engagement establish a 2-5 year pre-launch roadmap and milestones. Cross-functional & external leadership Serve as US commercial lead on global asset teams influence senior stakeholders without direct authority engage external stakeholders KOLs investigators scientific societies operate as a matrix leader across geographies and functions. Qualifications Education Bachelors degree required MBA or advanced degree preferred PharmD MBA Experience 8-12 years in pharmabiotech Experience in one or more New Product Planning Clinical Development Oncology MarketingMarket Access Medical Affairs Key Skills & Capabilities Strategic thinking ability to connect science market value Oncology expertise disease biology clinical pathways competitive landscape Immunology Experience Clinical-commercial integration fluency in both domains Market shaping mindset not just market entry Advanced analytics forecasting valuation scenario modeling Influence without authority in complex matrix organizations Strong communication translating complex science into clear strategy